Declining Innovation in Pharma

By Nathan Mata, Principal Consultant, Clinical Development 

I attended the NORD 2019 Summit in Washington, DC a few weeks ago. It was my first chance to attend this conference organized by the National Organization for Rare Diseases and, admittedly, the first time I considered going.